Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients

BACKGROUND: Fibroblast growth factor 21 (FGF21) is an emerging metabolic regulator associated with glucose and lipid metabolism, and it is still unclear whether FGF21 is related to atherosclerosis. Here, we explored the potential link between FGF21 and lower extremity atherosclerotic disease (LEAD)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Autores principales: Zhang, Xiaoyan, Hu, Yanyun, Zeng, Hui, Li, Lianxi, Zhao, Jungong, Zhao, Jun, Liu, Fang, Bao, Yuqian, Jia, Weiping
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359481/
https://ncbi.nlm.nih.gov/pubmed/25850006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0190-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares